Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

Fortunately for IPIX shareholders, BP doesn't need to believe Brilacidin is a miracle drug. They simply need to believe that it has a worth considerably more than $25 million. With two indications ready for phase 3 (ABSSSI and OM), one ready for phase 2B (UP), and numerous preclinical applications (HS, Acne, Atopic Dermatitis, coatings, etc.) they probably do.

That doesn't even count Kevetrin which as a phase 1 asset is worth far more than $25 million.

As always, it's about Leo and BP meeting in the middle and coming to an agreement. With no way for IPIX to move forward on it's own and significant incentive for Leo to make a deal (10's of millions of shares, 10's of millions of warrants that expire next year, $10 million loan into IPIX, etc.) I expect a good, solid deal will be struck. It may disappoint the $100/share dreamers but I think every one will end up green on their IPIX shares.

A miracle drug gets us billions. We don't need billions to have a very profitable investment.